Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00132795
Status:
COMPLETED
Last Update Posted:
2012-06-21
First Post:
2005-08-19
Brief Title:
Using Telephone Technology to Prevent Relapse After Alcoholism Treatment
Sponsor:
University of Vermont
Organization:
University of Vermont
Study Overview
Official Title:
Therapeutic IVR to Augment CBT in Alcohol Dependence
Status:
COMPLETED
Status Verified Date:
2012-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ATIVR
Brief Summary:
The purpose of this study is to determine whether a telephone based self-help program will prevent relapse among individuals undergoing standard substance abuse treatment
Detailed Description:
Relapse rates in the first few months following substance abuse treatment are as high as 50 in spite of the immediate effectiveness of treatments such as Cognitive Behavioral Therapy CBT Continuing use of therapy skills following treatment is associated with maintenance of treatment gains We have programmed a telephone to deliver pre-recorded summaries and rehearsal sessions of skills learned in therapy The system also includes monthly feedback messages from therapists We expect that this ad-lib access to therapy skills would allow patients to generalize skills to their personal post-treatment lives It would also allow individuals in remote or rural areas to obtain access to assistance without travel barriers
Comparisons patients completing group CBT for substance abuse will be randomly assigned to two conditions In one condition patients will have unlimited access to the therapeutic telephone system for 4 months The other condition is standard care ie no formal relapse prevention
Comparisons patients completing group CBT for substance abuse will be randomly assigned to two conditions In one condition patients will have unlimited access to the therapeutic telephone system for 4 months The other condition is standard care ie no formal relapse prevention
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01AA014270 | NIH | None | httpsreporternihgovquickSearchR01AA014270 |